Ternary Therapeutics is a biotechnology research center that specializes in bioinformatics and medicinal chemistry services.
Ternary Therapeutics has raised $4.8M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Ternary Therapeutics's investors include Daphni, UK Innovation & Science Seed Fund, Pace Ventures, i&i Biotech Fund.
Ternary Therapeutics is headquartered in London, United Kingdom.
Ternary Therapeutics is a biotechnology research center that specializes in bioinformatics and medicinal chemistry services.
Ternary Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ternary Therapeutics — Funding & Investors." VCBacked, March 16, 2026, https://www.vcbacked.co/company/ternary-therapeutics. Accessed August 13, 2026.
VCBacked. (2026). Ternary Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/ternary-therapeutics
{{cite web |title=Ternary Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ternary-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated